Zynerba Pharmaceuticals (ZYNE)

[Leonard McKinley]

I think that these various class action suits are having a bigger negative effect on the price of the stock than I previously thought. Today's price slide commenced shortly after yet another class action law suit press release. Personally, I think these suits have no merit but they are likely to be a distraction and annoyance to management.
These suits and likely tax loss selling seems likely to keep the price down until the New Year. Just a theory.